Nkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost Measures
16 Octobre 2023 - 10:01PM
Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing
engineered natural killer (NK) cell therapies, today announced that
it will host a conference call on Tuesday, October 17, 2023 at 8:00
a.m. ET to discuss clinical program updates and organizational cost
measures and resource prioritization to support clinical
milestones.
Conference Call and WebcastTo access the
conference call, please register through this link:
https://nkarta-business-update.open-exchange.net/registration
A replay will be archived on the Investors section of Nkarta’s
website, www.nkartatx.com, for approximately four weeks.
About NkartaNkarta is a clinical-stage
biotechnology company advancing the development of allogeneic,
off-the-shelf natural killer (NK) cell therapies. By combining its
cell expansion and cryopreservation platform with proprietary cell
engineering technologies and CRISPR-based genome engineering
capabilities, Nkarta is building a pipeline of future cell
therapies engineered for deep therapeutic activity and intended for
broad access in the outpatient treatment setting. For more
information, please visit the company’s website at
www.nkartatx.com.
Nkarta Media/Investor Contact:Greg MannNkarta,
Inc.gmann@nkartatx.com
Nkarta (NASDAQ:NKTX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Nkarta (NASDAQ:NKTX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024